Literature DB >> 36152369

Unusual presentation of Ewing sarcoma; a case report and literature review.

Abdullah Y Al-Marshad1, Ibrahim S AlMazrua2, Farah AlMulla3, Mohammed Alaboud4, Omar Alrifaie4, Mahmoud Shaheen4, Pant Rajeev4.   

Abstract

Introduction and importance Ewing's sarcoma is an aggressive malignancy primarily affecting skeletal system in children and young adults. CASE
PRESENTATION: We report an unusual case of Ewing sarcoma in a 14-year-old boy with clinical and radiological features of rapid onset metachronous skeletal metastasis (within 4 weeks of diagnosis). CLINICAL DISCUSSION: Although the deterioration of symptoms was very rapid, it is unusual to note that in the presence of such widespread metastatic disease the lungs per se remained uninvolved.
CONCLUSION: We describe a unique case of metastatic Ewing's sarcoma who showed rapid systemic disease progression with widespread skeletal metastases (and CNS involvement) but without any evidence of pulmonary involvement.
Copyright © 2022. Published by Elsevier Ltd.

Entities:  

Keywords:  Atypical; Ewing; Presentation; Sarcoma

Year:  2022        PMID: 36152369      PMCID: PMC9568706          DOI: 10.1016/j.ijscr.2022.107479

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  18 in total

Review 1.  The Biology of Ewing sarcoma.

Authors:  Nicolò Riggi; Ivan Stamenkovic
Journal:  Cancer Lett       Date:  2007-01-23       Impact factor: 8.679

2.  Age dependency of primary tumor sites and metastases in patients with Ewing sarcoma.

Authors:  Jennifer Worch; Andreas Ranft; Steven G DuBois; Michael Paulussen; Heribert Juergens; Uta Dirksen
Journal:  Pediatr Blood Cancer       Date:  2018-06-01       Impact factor: 3.167

Review 3.  Ewing's sarcoma.

Authors:  R Vlasak; F H Sim
Journal:  Orthop Clin North Am       Date:  1996-07       Impact factor: 2.472

Review 4.  Ewing sarcoma.

Authors:  Eun-Young K Choi; Jerad M Gardner; David R Lucas; Jonathan B McHugh; Rajiv M Patel
Journal:  Semin Diagn Pathol       Date:  2014-01-05       Impact factor: 3.464

5.  Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60: report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years.

Authors:  Gaetano Bacci; Alba Balladelli; Cristiana Forni; Stefano Ferrari; Alessandra Longhi; Patrizia Bacchini; Marco Alberghini; Nicola Fabbri; Mariaserena Benassi; Antonio Briccoli; Piero Picci
Journal:  Cancer       Date:  2007-02-15       Impact factor: 6.860

6.  The SCARE 2020 Guideline: Updating Consensus Surgical CAse REport (SCARE) Guidelines.

Authors:  Riaz A Agha; Thomas Franchi; Catrin Sohrabi; Ginimol Mathew; Ahmed Kerwan
Journal:  Int J Surg       Date:  2020-11-09       Impact factor: 6.071

7.  Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.

Authors:  Ruth Ladenstein; Ulrike Pötschger; Marie Cécile Le Deley; Jeremy Whelan; Michael Paulussen; Odile Oberlin; Henk van den Berg; Uta Dirksen; Lars Hjorth; Jean Michon; Ian Lewis; Alan Craft; Heribert Jürgens
Journal:  J Clin Oncol       Date:  2010-06-14       Impact factor: 44.544

8.  Evaluation of the child with a bone or soft-tissue neoplasm.

Authors:  G D Letson; G B Greenfield; S D Heinrich
Journal:  Orthop Clin North Am       Date:  1996-07       Impact factor: 2.472

9.  Intracranial dural metastasis of Ewing's sarcoma: a case report.

Authors:  Eung Yeop Kim; Seung Koo Lee; Dong Joon Kim; Jinna Kim; Kyu Sung Lee; Woohee Jung; Dong Ik Kim
Journal:  Korean J Radiol       Date:  2008 Jan-Feb       Impact factor: 3.500

10.  Outcomes of 50 Patients With Ewing Sarcoma Family of Tumors Treated at a Single Institution in Taiwan.

Authors:  Chih-Ying Lee; Chueh-Chuan Yen; Hsiu-Ju Yen; Cheng-Ying Shiau; Ta-Chung Chao; Po-Kuei Wu; Cheng-Fong Chen; Paul Chih-Hsueh Chen; Hung-Ta Hondar Wu; Hong-Jen Chiou; Chao-Chun Chen; Giun-Yi Hung; Wei-Ming Chen
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.